货号:GS40740
Tozorakimab is a humanized monoclonal antibody targeting interleukin-33 (IL-33), a cytokine released by epithelial and stromal cells upon tissue injury. It binds to IL-33, blocking its interaction with the ST2 receptor to suppress type 2 inflammation and tissue remodeling. It is being developed for the treatment of fibrotic and inflammatory lung diseases, such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD).
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯